Variation in world wide incidence of amyotrophic lateral sclerosis: A meta-analysis

International Journal of Epidemiology

Volumn 46, Issue 1, 2017, Pages 57-74

  Marin, Benoît ^a,b,c,d   Boumé diene, Farid ^a,b   Logroscino, Giancarlo ^d   Couratier, Philippe ^a,b   Babron, Marie Claude ^e   Leutenegger, Anne Louise ^e   Copetti, Massimilano ^f   Preux, Pierre Marie ^a,b   Beghi, Ettore ^c  

^a UNIVERSITÉ DE LIMOGES   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e Centre D'Etude du Polymorphisme Humain   (France)

^f CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Epidemiology; Ethnic groups; Incidence

Indexed keywords

DATABASE; DISEASE INCIDENCE; EPIDEMIOLOGY; ETHNIC GROUP; GEOGRAPHICAL VARIATION; GLOBAL PERSPECTIVE; HEALTH SURVEY; META-ANALYSIS; NERVOUS SYSTEM DISORDER; PUBLIC HEALTH; STANDARDIZATION;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASIA; CHINA; EMBASE; EUROPE; FOLLOW UP; HUMAN; INCIDENCE; IRAN; JAPAN; MEDLINE; META ANALYSIS; NEW ZEALAND; NORTH AMERICA; PRIORITY JOURNAL; SOUTH ASIA; SYSTEMATIC REVIEW; AGE; SEX FACTOR;

EUROPE; FAR EAST; NEW ZEALAND; NORTH AMERICA; SOUTH ASIA;

AGE FACTORS; AMYOTROPHIC LATERAL SCLEROSIS; ASIA; EUROPE; HUMANS; INCIDENCE; NEW ZEALAND; NORTH AMERICA; SEX FACTORS;

EID: 85019750088     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyw061     Document Type: Article

References (125)

1. Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology 2007;68: 1002-07
2. Chio., Logroscino G, Traynor BJ et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 2013;41:118-30
3. Joensen P. Incidence of amyotrophic lateral sclerosis in the Faroe Islands. Acta Neurol Scand 2012;126:62-66
4. Murphy M, Quinn S, Young J, Parkin P, Taylor B. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology 2008;71:1889-95
5. Gordon PH, Mehal JM, Holman RC, Rowland LP, Rowland AS, Cheek JE. Incidence of amyotrophic lateral sclerosis among American Indians and Alaska natives. JAMA Neurol 2013;70:476-80
6. Sajjadi M, Etemadifar M, Nemati A et al. Epidemiology of amyotrophic lateral sclerosis in Isfahan, Iran. Eur J Neurol 2010;17:984-89
7. Bucheli M, Andino A, Montalvo M et al. Amyotrophic lateral sclerosis: Analysis of ALS cases in a predominantly admixed population of Ecuador. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:106-13
8. Marin B, Hamidou B, Couratier P et al. Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe-the French register of ALS in Limousin (FRALim register). Eur J Neurol 2014;21:1292-300
9. Uenal H, Rosenbohm A, Kufeldt J et al. ALS registry study group. Incidence and geographical variation of amyotrophic lateral sclerosis (ALS) in Southern Germany-completeness of the ALS registry Swabia. PLoS One 2014;9:e93932
10. Wolf J, Wohrle JC, Palm F et al. Incidence of amyotrophic lateral sclerosis in Rhineland-Palatinate, Germany. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:269-74
11. Freer C, Hylton T, Jordan HM, Kaye WE, Singh S, Huang Y. Results of Florida's Amyotrophic Lateral Sclerosis Surveillance Project, 2009-2011. BMJ Open 2015;5:e007359
12. Jordan H, Rechtman L, Wagner L, Kaye WE. Amyotrophic lateral sclerosis surveillance in Baltimore and Philadelphia. Muscle Nerve 2015;51:815-21
13. Lannuzel A, Mecharles S, Tressieres B et al. Clinical varieties and epidemiological aspects of amyotrophic lateral sclerosis in the Caribbean island of Guadeloupe: A new focus of ALS associated with Parkinsonism. Amyotroph Lateral Scler Frontotemporal Degener 2015;16:216-23
14. Valle J, oberts E, Aulukonis S, Collins N, English P, Kaye W. Epidemiology and surveillance of amyotrophic lateral sclerosis in two large metropolitan areas in California. Amyotroph Lateral Scler Frontotemporal Degener 2015;16:209-15
15. Marin B, Couratier P, Preux PM, Logroscino G. Can mortality data be used to estimate amyotrophic lateral sclerosis incidence? Neuroepidemiology 2011;36:29-38
16. Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology 2009;72:1640-45
17. Stroup DF, Berlin JA, Morton SC et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12
18. Fiest KM, Pringsheim T, Patten SB, Svenson LW, Jette N. The role of systematic reviews and meta-analyses of incidence and prevalence studies in neuroepidemiology. Neuroepidemiology 2014;42:16-24
19. Mitsumoto H, Chad AD, Pioro EP, Amyotrophic lateral sclerosis. In: Amyotrophic Lateral Sclerosis. Philadelphia, PA: Davis, 1998
20. Szklo M. Population-based cohort studies. Epidemiol Rev. 1998;20:81-90
21. United Nations Statistics Division. Composition of Macro Geographical (Continental) Regions, Geographical Sub-Regions, and Selected Economic and Other Groupings. https:// unstats.un.org/unsd/methods/m49/m49regin.htm (9 January 2015, date last accessed)
22. Plato CC, Garruto RM, Galasko D et al. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. Am J Epidemiol 2003;157: 149-57
23. United Nations. Demographic Yearbook. https://unstats.un. org/unsd/demographic/products/dyb/dyb2.html (25 June 2015, date last accessed)
24. United States Census Bureau. National Estimates by Age, Sex, Race: 1900-1979. http://www.census.gov/popest/data/national/ asrh/pre-1980/PE-11.html (9 January 2015, date last accessed)
25. United States Census Bureau. International Data Base. 2010. http://www.census.gov/population/international/data/idb/ informationGateway.php (25 June, 2015, date last accessed)
26. United States Census Bureau. 2010 Census Data Products: United States. 2010. https://www.census.gov/population/www/ cen2010/glance/(9 January 2015, date last accessed)
27. Sterne J, Bradburn M, Egger M. Meta-analysis in Stata, in Systematic Reviews in Health Care: Meta-Analysis in Context. BMJ Publishing 2008:347-69
28. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60
29. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002;21:1559-73
30. Egger M, Davey SG, Altman DG. Systematic Reviews in Health Care: Meta-Analysis in Context. Chichester, UK: Wiley, 2008
31. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases, and the El Escorial Clinical Limits of Amyotrophic Lateral Sclerosis' workshop contributors. J Neurol Sci 1994;124 (Suppl):96-107
32. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-99
33. Gunnarsson LG, Palm R. Motor neuron disease and heavy manual labor: an epidemiologic survey of Varmland County, Sweden. Neuroepidemiology 1984;3: 195-206
34. Forsgren L, Almay BGL, Holmgren G, Wall S. Epidemiology of motor neuron disease in northern Sweden. Acta Neurol Scand.1983;68: 20-29
35. Murros K, Fogelholm R. Amyotrophic lateral sclerosis in Middle-Finland: an epidemiological study. Acta Neurol Scand 1983;67:41-47
36. Højer-Pedersen E, Christensen PB, Jensen NB. Incidence and prevalence of motor neuron disease in two Danish counties. Neuroepidemiology 1989;8:151-59
37. Forbes RB, Colville S, Parratt J, Swingler RJ. The incidence of motor nueron disease in Scotland. J Neurol 2007;254:866-69
38. Imam I, Ball S, Wright D, Hanemann CO, Zajicek J. The epidemiology of motor neurone disease in two counties in the southwest of England. J Neurol 2010;257:977-81
39. Logroscino G, Traynor BJ, Hardiman O et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 2010;81:385-90
40. O'TooleO, Traynor BJ, Brennan P et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. JNeurolNeurosurg Psychiatry 2008;79:30-32
41. Gross-Paju K, Oopik M, Luus SM et al. Motor neurone disease in South Estonia. Diagnosis and incidence rate. Acta Neurol Scand 1998;98:22-28
42. Huisman MH, de Jong SW, van Doormaal PT et al. Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol Neurosurg Psychiatry 2011;82:1165-70
43. Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G. Incidence of ALS in Lombardy, Italy. Neurology 2007;68:141-45
44. Chio A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology 2009;72:725-31
45. Drigo D, Verriello L, Clagnan E et al. The incidence of amyotrophic lateral sclerosis in Friuli Venezia Giulia, Italy, from 2002 to 2009: a retrospective population-based study. Neuroepidemiology 2013;41:54-61
46. Mandrioli J, Biguzzi S, Guidi C et al. Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): A population based study. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:262-68
47. Bandettini di Poggio M, Sormani MP, Truffelli R et al. Clinical epidemiology of ALS in Liguria, Italy. Amyotroph Lateral Scler Frontotemporal Degener 2013;14:52-57
48. Logroscino G, Beghi E, Zoccolella S et al. Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry 2005;76:1094-98
49. Pugliatti M, Parish LD, Cossu P et al. Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995-2009. J Neurol 2013;260:572-79
50. Ragonese P, Cellura E, Aridon P et al. Incidence of amyotrophic lateral sclerosis in Sicily: A population based study. Amyotroph Lateral Scler Frontotemporal Degener 2012;13:284-87
51. Pradas J, Puig T, Rojas-Garcia R, Viguera ML, Gich I, Logroscino G: and A.-C. Group. Amyotrophic lateral sclerosis in Catalonia: a population based study. Amyotroph Lateral Scler Frontotemporal Degener 2013;14:278-83
52. Hudson AJ, Davenport A, Hader WJ. The incidence of amyotrophic lateral sclerosis in Southwestern Ontario, Canada. Neurology 1986;36:1524-28
53. Bonaparte JP, Grant IA, Benstead TJ, Murray TJ, Smith M. ALS incidence in Nova Scotia over a 20-year-period: a prospective study. Can J Neurol Sci 2007;34:69-73
54. Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology 2002;59:280-82
55. McGuire V, Longstreth WT Jr, Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology 1996;47: 571-73
56. Annegers JF, Appel S, Lee JRJ, Perkins P. Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988. Arch Neurol 1991;48:589-93
57. Jordan H, Fagliano J, Rechtman L, Lefkowitz D, Kaye W. Population-based surveillance of amyotrophic lateral sclerosis in New Jersey, 2009-2011. Neuroepidemiology 2014;43:49-56
58. Bettini M, Vicens J, Giunta DH, Rugiero M, Cristiano E. Incidence and prevalence of amyotrophic lateral sclerosis in an HMO of Buenos Aires, Argentina. Amyotroph Lateral Scler Frontotemporal Degener 2013;14:598-603
59. Vazquez MC, Ketzoian C, Legnani C et al. Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a populationbased study. Neuroepidemiology 2008;30:105-11
60. Matsumoto N, Worth RM, Kurland LT, Okazaki H. Epidemiologic study of amyotrophic lateral sclerosis in Hawaii. Identification of high incidence among Filipino men. Neurology 1972;22:934-40
61. Radhakrishnan K, Ashok PP, Sridharan R, Mousa ME. Descriptive epidemiology of motor neuron disease in Benghazi, Libya. Neuroepidemiology 1986;5:47-54
62. Okumura H. Epidemiological and clinical patterns of western pacific amyotrophic lateral sclerosis (ALS) in Guam and sporadic ALS in Rochester, Minnesota, U.S.A. and Hokkaido, Japan: a comparative study.Hokkaido Igaku Zasshi 2003;78:187-95
63. Lai CH, Tseng HF. Epidemiology and medical expenses of motor neuron diseases in Taiwan. Neuroepidemiology 2008;31:159-66
64. Fong G.C, Cheng TS, Lam K et al. An epidemiological study of motor neuron disease in Hong Kong. Amyotroph Lateral Scler Other Motor Neuron Disord 2005;6:164-68
65. Kahana E, Zilber N. Changes in the incidence of amyotrophic lateral sclerosis in Israel. Arch Neurol 1984;41:157-60
66. Abhinav K, Stanton B, Johnston C et al. Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry). Neuroepidemiology 2007;29:44-48
67. Christensen PB, Hojer-Pedersen E, Jensen NB. Survival of patients with amyotrophic lateral sclerosis in 2 Danish counties. Neurology 1990;40:600-04
68. Forbes RB, Colville S, Cran GW, Swingler RJ. Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease. J Neurol Neurosurg Psychiatry 2004;75:1753-75
69. Chancellor AM, Slattery JM, Fraser H, Swingler RJ, Holloway SM, Warlow CP. The prognosis of adult-onset motor neuron disease: A prospective study based on the Scottish Motor Neuron Disease Register. J Neurol 1993;240:339-46
70. Chancellor AM, Swingler RJ, Fraser H, Clarke JA, Warlow CP. Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease. J Epidemiol Community Health 1993;47:116-20
71. Rooney J, Byrne S, Heverin M et al. Survival Analysis of Irish amyotrophic lateral sclerosis patients diagnosed from 1995-2010 PLoS One 2013;8.e74733
72. Phukan J, Elamin M, Bede P et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a populationbased study. J Neurol Neurosurg Psychiatry 2012;83:102-08
73. Donaghy C, Clarke J, Patterson C, Kee F, Hardiman O, Patterson V. The epidemiology of motor neuron disease in Northern Ireland using capture-recapture methodology. Amyotroph Lateral Scler Frontotemporal Degener 2010;11: 374-78
74. Donaghy C, O'Toole O, Sheehan C, Kee F, Hardiman O, Patterson V. An all-Ireland epidemiological study of MND, 2004-2005. Eur J Neurol 2009;16:148_53
75. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology 1999;52:504-09
76. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman OM. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study. Arch Neurol 2000;57:1171-76
77. Pupillo E, Messina P, Logroscino G, Beghi E. Long-term survival in amyotrophic lateral sclerosis: A population-based study. Ann Neurol 2014;75:287-97
78. Millul A, Beghi E, Logroscino G, Micheli A, Vitelli E, Zardi A. Survival of patients with amyotrophic lateral sclerosis in a population-based registry. Neuroepidemiology 2005;25: 114-19
79. Chio A, Cucatto A, Calvo A, Terreni AA, Magnani C, Schiffer D. Amyotrophic lateral sclerosis among the migrant population to Piemonte, northwestern Italy. J Neurol 1999;246:175-80
80. Chio A, Mora G, Leone M et al. Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology 2002;59:99-103
81. Chio A, Calvo A, Moglia C et al. Phenotypic heterogeneity of amyotrophic lateral sclerosis: A population based study. J Neurol Neurosurg Psychiatry 2011;82:740-46
82. Piemonte and Valle d'Aosta Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology 2001; 56:239-44
83. Mandrioli J, Faglioni P, Merelli E, Sola P. The epidemiology of ALS in Modena, Italy. Neurology 2003;60:683-89
84. Mandrioli J, Faglioni P, Nichelli P, Sola P. Amyotrophic lateral sclerosis: Prognostic indicators of survival. Amyotroph Lateral Scler Frontotemporal Degener 2006;7:217-26
85. Mandrioli J, Salvi F, Sette E et al. Amyotrophic lateral sclerosis in emilia romagna, Italy: A population based study from 2009 to 2011. the emiliaromagna register for ALS (errals). Amyotroph Lateral Scler Frontotemporal Degener 2012; 13:128
86. GovoniV, Granieri E, Capone J, Manconi M, Casetta I. Incidence of amyotrophic lateral sclerosis in the local health district of Ferrara, Italy, 1964-1998. Neuroepidemiology 2003; 22:229-34
87. Granieri E, Carreras M, Tola R et al., Motor neuron disease in the province of Ferrara, Italy, in 1964-1982. Neurology 1988;38:1604-08
88. Guidetti D, Bondavalli M, Sabadini R et al. Epidemiological survey of amyotrophic lateral sclerosis in the province of Reggio Emilia, Italy: influence of environmental exposure to lead. Neuroepidemiology 1996;15:301-12
89. Georgoulopoulou E, Vinceti M, Bonvicini F et al. Changing incidence and subtypes of ALS in Modena, Italy: A 10-years prospective study. Amyotroph Lateral Scler Frontotemporal Degener 2011;12:451-57
90. Bonvicini F, Vinceti M, Marcello N, Rodolfi R, Rinaldi M. The epidemiology of amyotrophic lateral sclerosis in Reggio Emilia, Italy. Amyotroph Lateral Scler Frontotemporal Degener 2008;9:350-53
91. Zoccolella S, Beghi E, Palagano G et al. Signs and symptoms at diagnosis of amyotrophic lateral sclerosis: a population-based study in southern Italy. Eur J Neurol 2006;13:789-92
92. Zoccolella S, Beghi E, Palagano G et al Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study. JNeurolNeurosurg Psychiatry 2008;79:33-37
93. Zoccolella S, Beghi E, Palagano G et al. Predictors of long survival in amyotrophic lateral sclerosis: a population-based study. J Neurol Sci 2008;268:28-32
94. Mateen FJ, Carone M, Sorenson EJ. Patients who survive 5 years or more with ALS in Olmsted County, 1925-2004. J Neurol Neurosurg Psychiatry 2010;81:1144-46
95. Mulder DW, Howard FM Jr. Patient resistance and prognosis in amyotrophic lateral sclerosis. Mayo Clin Proc 1976;51: 537-41
96. Yoshida S, Mulder DW, Kurland LT, Chu CP, Okazaki H. Follow-up study on amyotrophic lateral sclerosis in Rochester, Minn., 1925 through 1984. Neuroepidemiology 1986;5:61-70
97. del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 2003;60:813-19
98. Lee CT, Chiu YW, Wang KC et al. Riluzole and prognostic factors in amyotrophic lateral sclerosis long-term and short-term survival: a population-based study of 1149 cases in Taiwan. J Epidemiol 2013;23:35-40
99. Fong KY, Yu YL, Chan YW et al. Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture. Neuroepidemiology 1996;15:239-45
100. Gubbay SS, Kahana E, Zilber N, Cooper G, Pintov S, Leibowitz Y. Amyotrophic lateral sclerosis. A study of its presentation and prognosis. J Neurol 1985;232:295-300
101. Govoni V, Cesnik E, Casetta, I, Tugnoli V, Tola MR, Granieri E. Temporal trend of amyotrophic lateral sclerosis incidence in southern Europe: a population study in the health district of Ferrara, Italy. J Neurol 2012;259:1623-31
102. Johnston CA, Stanton BR, Turner MR et al. Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. J Neurol 2006;253: 1642-43
103. Manjaly ZR, Scott KM, Abhinav K et al. The sex ratio in amyotrophic lateral sclerosis: A population based study. Amyotroph Lateral Scler Frontotemporal Degener2010;11:439-42
104. Rojas-Garcia R, Scott KM, Roche JC et al. No evidence for a large difference in ALS frequency in populations of African and European origin: a population based study in inner city London. Amyotroph Lateral Scler Frontotemporal Degener 2012;13:66-68
105. Scott KM, Abhinav K, Stanton BR et al Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study. Neuroepidemiology 2009;32:81-88
106. Scott KM, Abhinav K, Wijesekera L et al. The association between ALS and population density: A population based study. Amyotroph Lateral Scler Frontotemporal Degener 2010;11:435-38
107. Norris F, Shepherd R, Denys E et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 1993;118:48-55
108. Kihira T, Yoshida S, Hironishi M, Miwa H, Okamato K, Kondo T. Changes in the incidence of amyotrophic lateral sclerosis in Wakayama, Japan. Amyotroph Lateral Scler Other Motor Neuron Disord 2005;6:155-63
109. Yoshida S, Uebayashi Y, Kihira T et al. Epidemiology of motor neuron disease in the Kii Peninsula of Japan, 1989-1993: active or disappearing focus? J Neurol Sci 1998;155:146-55
110. Kihira T, Yoshida S, Kondo T et al. An increase in ALS incidence on the Kii Peninsula, 1960-2009: a possible link to change in drinking water source. Amyotroph Lateral Scler Frontotemporal Degener 2012;13:347-50
111. Wolf J, Safer A, Wohrle JC et al. Variability and prognostic relevance of different phenotypes in amyotrophic lateral sclerosis-Data from a population-based registry. J Neurol Sci 2014;345:164-67
112. Okumura H, Moriwaka F, Tashiro K et al. [Epidemiological study of motor neuron disease in Hokkaido island-its incidence, prevalence and regional distributions-ALS Study Group]. No To Shinkei 1992;44:727-32
113. Rechtman L, Jordan H, Wagner L, Horton DK, Kaye W. Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States. Amyotroph Lateral Scler Frontotemporal Degener 2015;16:65-71
114. Wagner L, Rechtman L, Jordan H et al. State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance. Amyotroph Lateral Scler Frontotemporal Degener 2015; 17:128-34
115. Lasser KE, Himmelstein DU, Woolhandler S. Access to care, health status, and health disparities in the United States and Canada: results of a cross-national population-based survey. Am J Public Health 2006;96:1300-07
116. Chang MH, Molla MT, Truman BI, Athar H, Moonesinghe R, Yoon PW. Differences in healthy life expectancy for the US population by sex, race/ethnicity and geographic region: 2008. J Public Health (Oxf) 2015;37:470-79
117. Marin B, Kacem I, Diagana M et al. Juvenile and adult-onset ALS/MND among Africans: incidence, phenotype, survival: a review. Amyotroph Lateral Scler Frontotemporal Degener. 2012;13:276-83
118. Logroscino G, Tortelli R, Rizzo G, Marin B, Preux PM, Malaspina A. Amyotrophic Lateral Sclerosis: An Aging-Related Disease. Curr Geriatr Rep 2015;4:142-53
119. LogroscinoG, Traynor BJ, HardimanOet al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. JNeurolNeurosurg Psychiatry 2008;79:6-11
120. Lee JR, Annegers JF, Appel SH. Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci 1995;132:207-15
121. Bettini M, Gargiulo-Monachelli GM, Rodriguez G, Rey RC, Peralta LM, Sica RE. Epidemiology of amyotrophic lateral sclerosis patients in a centre in Buenos Aires. Arq Neuropsiquiatr 2011;69:867-70
122. Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol 2013;9:617-28
123. Mehta KM, Yaffe K, Perez-Stable EJ et al. Race/ethnic differences in AD survival in US Alzheimer's Disease Centers. Neurology 2008;70:1163-70
124. Helzner EP, Scarmeas N, Cosentino S, TangMX, Schupf N, Stern Y. Survival in Alzheimer disease: a multiethnic, population-based study of incident cases. Neurology 2008;71:1489-95
125. Marin B, Logroscino G, Boumediene F et al. Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol 2016;41:229-45